Related references
Note: Only part of the references are listed.Outcomes Following Ischemic Stroke in Older Patients With CKD Stages 4 and 5: A Retrospective Cohort Study
James B. Wetmore et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2020)
Risk of hospitalised bleeding in comparisons of oral anticoagulant options for the primary treatment of venous thromboembolism
Pamela L. Lutsey et al.
BRITISH JOURNAL OF HAEMATOLOGY (2019)
Rural-Urban Differences in Stroke Risk Factors, Incidence, and Mortality in People With and Without Prior Stroke The CANHEART Stroke Study
Moira K. Kapral et al.
CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES (2019)
Early withdrawal and non-withdrawal death in the months following hemodialysis initiation: A retrospective cohort analysis
James B. Wetmore et al.
HEMODIALYSIS INTERNATIONAL (2019)
2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society
Craig T. January et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2019)
Shifting to a non-vitamin K antagonist oral anticoagulation agent from vitamin K antagonist in atrial fibrillation
Emil L. Fosbol et al.
EUROPACE (2018)
Factors Associated With Withdrawal From Maintenance Dialysis: A Case-Control Analysis
James B. Wetmore et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2018)
Chronic kidney disease and arrhythmias: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
Mintu P. Turakhia et al.
EUROPEAN HEART JOURNAL (2018)
The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation
Jan Steffel et al.
EUROPEAN HEART JOURNAL (2018)
Trends in initiation of direct oral anticoagulant therapies for atrial fibrillation in a national population-based cross-sectional study in the French health insurance databases
Laetitia Huiart et al.
BMJ OPEN (2018)
Provider Specialty, Anticoagulation Prescription Patterns, and Stroke Risk in Atrial Fibrillation
Wesley T. O'Neal et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2018)
Antithrombotic Therapy for Atrial Fibrillation CHEST Guideline and Expert Panel Report
Gregory Y. H. Lip et al.
CHEST (2018)
Geovariation in Fracture Risk among Patients Receiving Hemodialysis
James B. Wetmore et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2016)
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS
Paulus Kirchhof et al.
EUROPEAN HEART JOURNAL (2016)
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
Craig T. January et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2014)
Differences and trends in stroke prevention anticoagulation in primary care vs cardiology specialty management of new atrial fibrillation: The Retrospective Evaluation and Assessment of Therapies in AF (TREAT-AF) study
Mintu P. Turakhia et al.
AMERICAN HEART JOURNAL (2013)
Identifying the Risks of Anticoagulation in Patients with Substance Abuse
Lydia M. Efird et al.
JOURNAL OF GENERAL INTERNAL MEDICINE (2013)
Edoxaban versus Warfarin in Patients with Atrial Fibrillation
Robert P. Giugliano et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Personalizing oral anticoagulant treatment in patients with atrial fibrillation
Piera Capranzano et al.
EXPERT REVIEW OF CARDIOVASCULAR THERAPY (2013)
Predictors of warfarin use in atrial fibrillation in the United States: a systematic review and meta-analysis
Victoria L. Baczek et al.
BMC FAMILY PRACTICE (2012)
Chronic Kidney Disease Is Associated With the Incidence of Atrial Fibrillation The Atherosclerosis Risk in Communities (ARIC) Study
Alvaro Alonso et al.
CIRCULATION (2011)
Apixaban versus Warfarin in Patients with Atrial Fibrillation
Christopher B. Granger et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
Manesh R. Patel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
An automated database case definition for serious bleeding related to oral anticoagulant use
Andrew Cunningham et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2011)
A Novel User-Friendly Score (HAS-BLED) To Assess 1-Year Risk of Major Bleeding in Patients With Atrial Fibrillation The Euro Head Survey
Ron Pisters et al.
CHEST (2010)
Refining Clinical Risk Stratification for Predicting Stroke and Thromboembolism in Atrial Fibrillation Using a Novel Risk Factor-Based Approach The Euro Heart Survey on Atrial Fibrillation
Gregory Y. H. Lip et al.
CHEST (2010)
Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis
Kunihiro Matsushita et al.
LANCET (2010)
Close bidirectional relationship between chronic kidney disease and atrial fibrillation: The Niigata preventive medicine study
Hiroshi Watanabe et al.
AMERICAN HEART JOURNAL (2009)
Dabigatran versus Warfarin in Patients with Atrial Fibrillation.
Stuart J. Connolly et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data
HD Quan et al.
MEDICAL CARE (2005)
Share Paper
